Skip to main content
OpenTrials
Completed

NCT Number: NCT03177655

Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis

This single-center interventional study quasi-randomly allocated patients to a guided imagery or control intervention (positive journaling). Data were analyzed with treatment allocation masked.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California, San Diego

San Diego, California, 92103, United States

About this study

Interventions: Participants were assigned in alternate order to 10 weekly 1-hour sessions "Healing Light Guided Imagery" or at-home positive journaling; drop-outs were replaced.

Intervention Type: Behavioral

Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord (central nervous system). Because nerves in any part of the brain or spinal cord may be damaged, patients with multiple sclerosis can have symptoms in different parts of the body. Many Multiple Sclerosis patients suffer from depression, fatigue and anxiety in addition to physical symptoms. Drugs prescribed for MS have been shown to not improve these comorbid psychological symptoms. Researchers have shown that mindfulness-based training programs can help MS patients, but these therapies are highly resource demanding and taxing for those involved. "Healing Light" Guided Imagery (HLGI; supplementary materials) is a guided imagery therapy that simulates a self-hypnotic trance state that has been anecdotally shown to improve depression and fatigue in patients with MS in less time and with fewer support resources. The investigators plan to test whether HLGI can increase patient well-being.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of Relapsing-Remitting Multiple Sclerosis
  • 18-70 years old
  • Able to read and write in English
  • Able to attend sessions at the UC San Diego School of Medicine
  • Age group: adult
  • Gender: both
  • Target enrollment: 20

Participant exclusion criteria:

  • Severe depression (score of 31 or higher on the BDI)
  • Very high levels of fatigue (above an average of 6 on the FSS)
  • Low levels of mindfulness (below an average score of 2 on the FMI).

Treatment and study plan

guided imagery

Other

Guided Imagery meditation

Journaling

Other

Keeping a journal

Primary outcomes

  1. Quality of Life (MS-QOL-54)

    Time frame: Change from baseline at 10 weeks

    Quality of Life based on Multiple Sclerosis Quality of Life Instrument (MS-QOL-54)

Secondary outcomes

  1. Mood (BDI-II)

    Time frame: Change from baseline at 10 weeks

    Depressed mood based on the Beck Depression Inventory II (BDI-II)

  2. Fatigue (FSS)

    Time frame: Change from baseline at 10 weeks

    Fatigue levels based on the Fatigue Severity Scale (FSS)

Sponsors and collaborators

Lead sponsor

University of California, San Diego

Other

Registry information

Acronym: HLGI

Important dates

Study start
2012
Primary completion
2017
Study completion
2017
First posted
Jun 6, 2017
Registry last updated
Jun 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.